BUPIVACAINE HYDROCHLORIDE WITH DEXTROSE
Generic: BUPIVACAINE HYDROCHLORIDE WITH DEXTROSE
BUPIVACAINE HYDROCHLORIDE WITH DEXTROSE is FDA application ANDA209087, sponsored by B BRAUN MEDICAL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Presence of particulate matter: visible free floating and partially embedded particulate matter in t
cGMP deviations: Temperature abuse
Presence of particulate matter: visible free floating and partially embedded particulate matter in t
Presence of Particulate Matter: Confirmed customer report of visible particulate embedded in the gla
Lack of assurance of sterility; equipment failure led to potential breach in asceptic process.
Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles.
Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP
Presence of particulate matter: Confirmed customer report for the presence of particulate matter wit
Lack of Assurance of Sterility; potential for vial breakage
Lack of Assurance of Sterility